Oscar Health, Inc. (OSCR): Among Michael Burry Stocks with Huge Upside Potential
We recently published a list of . In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other Michael Burry stocks with huge upside potential.
Michael Burry, founder and manager of Scion Asset Management, is best known for predicting and profiting from the housing bubble's collapse in the mid-2000s. His bold contrarian bet was famously chronicled in the book and film 'The Big Short.' Burry's investment strategy draws heavily from the rigorous market analysis and principles outlined in Benjamin Graham and David Dodd's 1934 book 'Security Analysis.' The book championed the merits of financial statement analysis, highlighting the importance of intrinsic value and structured investment principles.
That said, Burry has never shied away from putting his own distinct stamp on Wall Street's time-tested principles. By utilizing complex financial tools, such as derivative securities and short-selling, Burry has amassed a fortune, challenging conventional market wisdom. His 2001 Scion Value Fund letter provides a fascinating insight into his contrarian outlook, which prioritizes long-term value over short-term price fluctuations. Burry makes it clear that to achieve significant long-term returns, he is willing to tolerate short-term volatility. He stated:
'I will always choose the dollar bill carrying a wildly fluctuating discount rather than the dollar bill selling for a quite stable premium.'
He also has no qualms about making significant investments in a few stocks that he believes are undervalued, a tactic the investor employed to strengthen Scion's holdings at the end of 2024.
In the quarter that ended on December 31, 2024 just before DeepSeek's artificial intelligence breakthrough sparked a $1.3 trillion surge in Chinese tech stocks, Michael Burry offloaded some of his investments in the country's tech stocks. The moves came amid a period of high volatility for Chinese stocks, when investors appeared to be losing faith in Beijing following the implementation of a stimulus package in late September. The government's actions triggered a wild rally until early October, though momentum waned due to a property crisis, a poor economic outlook, and dissatisfaction with the scope of fiscal stimulus in the following months.
For this article, we examined Scion Asset Management's Q4 2024 13F filings to list down Michael Burry's stock picks with the highest upside potential. We ranked the companies in ascending order of their upside potential. These equities are also popular among elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care.Oscar Health, Inc. (NYSE:OSCR) is a health insurance company which makes use of a full-stack technology platform to offer and manage insurance. Its primary operations and services include health insurance plans, technology platform +Oscar, and member services. The company focuses on the health insurance sector through telemedicine, healthcare-focused technological interfaces, and transparent claims pricing systems.
On May 7, Oscar Health, Inc. (NYSE:OSCR) announced first-quarter revenue and earnings that surpassed analyst expectations. The company reported adjusted earnings per share of $0.92, exceeding the consensus estimate of $ 0.81. Revenue for the quarter was $3.05 billion, surpassing the forecast of $2.84 billion and representing a 42% year-over-year increase from the $2.14 billion in Q1 2024. As of March 31, the company had over 2 million members, up from 1.45 million the previous year.
Artificial Intelligence is another area of growth for the company. During Oscar Health's fourth-quarter results call, CEO Mark Bertolini stated that the company is rapidly deploying artificial intelligence in additional areas of its business. He stated that last year, the company implemented AI in 11 new use cases. Ten further use cases are being planned for the first quarter of 2025.
Longleaf Partners Small-Cap Fund stated the following regarding Oscar Health, Inc. (NYSE:OSCR) in its Q4 2024 investor letter:
'Oscar Health, Inc. (NYSE:OSCR) – Health insurance and software company Oscar was a top detractor for the quarter while remaining a top contributor for the year. The company delivered another strong quarter operationally, achieving over 60% year-over-year revenue and membership growth, while advancing toward its publicly stated goal of 5% operating income margins. Despite the operational progress, the Trump presidential win weighed on the stock price in the quarter due to added uncertainty around the future of the enhanced ACA subsidies set to expire at the end of 2025 and broader implications for the ACA itself. Oscar still has underappreciated non-earning assets in various regions at different stages of ramp-up, transitioning from investment mode in some areas to higher-margin operations in others. We view this as a long-term positive, highlighting the embedded long-term growth potential at Oscar. While election-related news contributed to stock volatility in the second half of the year, we capitalized on the volatility by strategically trimming and adding to our position. It was powerful to see both co-founder Josh Kushner and CEO Mark Bertolini (via his foundation) each purchase more than $10 million worth of stock in the wake of the election selloff.'
Overall, OSCR ranks 6th on our list of Michael Burry stocks with huge upside potential. While we acknowledge the potential for OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than OSCR but trades at less than 5 times its earnings, check out our report about this .
READ NEXT: and .
Disclosure: None. This article is originally published at .
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Oscar Health (OSCR) Skyrockets 52% W/W. Time to Take Profits?
Oscar Health, Inc. (NYSE:OSCR) is one of the . Oscar Health jumped by 52 percent week-on-week, finishing at $21.22 versus the $13.95 on June 13, with analysts naming it a meme stock amid the lack of clear catalysts to boost buying appetite. Last week's shortened trading saw Oscar Health, Inc. (NYSE:OSCR) trade higher for four consecutive days, reflecting strong investor confidence amid macroeconomic uncertainties. Additionally, sentiment may have been supported by a new proposal for the Medicare Advantage, called 'Part E,' that would allow individuals and employers to enroll voluntarily. While this would heighten competition with private insurers, the voluntary enrollment could potentially delay or prevent Medicare's sooner-than-expected insolvency, and indirectly benefit Oscar Health, Inc. (NYSE:OSCR) and other private insurers. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
an hour ago
- CNBC
U.S. calls on China to prevent Iran from closing Strait of Hormuz and disrupting global oil flows
U.S. Secretary of State Marco Rubio on Sunday called for China to prevent Iran from closing the Strait of Hormuz, one of the most important trade routes for crude oil in the world. "I encourage the Chinese government in Beijing to call them about that, because they heavily depend on the Straits of Hormuz for their oil," Rubio said in an interview on Fox News. China is Iran's most important oil customer and maintains friendly relations with the Islamic Republic. Iran's foreign minister warned earlier Sunday that the Islamic Republic "reserves all options to defend its sovereignty," after the U.S. bombed three key nuclear sites over the weekend. Iranian state-owned media, meanwhile, reported that Iran's parliament backed closing the Strait of Hormuz, citing a senior lawmaker. However, the final decision to close the strait lies with Iran's national security council, according to the report. An attempt to block the narrow waterway between Iran and Oman could have profound consequences for the global economy. Some 20 million barrels per day of crude oil, or 20% of global consumption, flowed through the strait in 2024, according to the Energy Information Administration. Oil prices could shoot above $100 per barrel if the strait is closed for a prolonged period, according to Goldman Sachs and consulting firm Rapidan Energy. Iran is the third-largest oil producer in OPEC, pumping 3.3 million barrels per day. The Islamic Republic exports at least 1.6 million bpd, with nearly 80% sold to China, according to the EIA. Rubio said it would be "economic suicide" for Iran to close the strait. "We retain options to deal with that," the U.S. secretary of state said. "It would hurt other countries' economies a lot worse than ours," Rubio said. "It would be, I think, a massive escalation that would merit a response, not just by us, but from others." The U.S. Fifth Fleet is stationed in Bahrain and tasked with protecting maritime trade in the Persian Gulf. Oil market participants generally believe the U.S. Navy would swiftly vanquish any attempt by Iran to block the Strait of Hormuz. But some analysts warn that the market is underestimating the risk. "They could disrupt, in our view, shipping through Hormuz by a lot longer than the market thinks," said Bob McNally, founder of Rapidan Energy and former energy advisor to President George W. Bush. Shipping could be interrupted for weeks or months, McNally said, rather than the oil market's view that the U.S. Navy would resolve the situation in hours or days. "It would not be a cakewalk," McNally told CNBC.
Yahoo
2 hours ago
- Yahoo
Better Cybersecurity Stock: CrowdStrike or SentinelOne?
CrowdStrike and SentinelOne have similar business models and offerings. CrowdStrike is much larger. SentinelOne trades at a steep discount to CrowdStrike. 10 stocks we like better than CrowdStrike › Artificial intelligence (AI) may have many benefits, but it's also making it easier for hackers, online criminals, and other digital malefactors to threaten businesses, and those threats are getting more potent. Keeping them at bay requires a lot of funds to be devoted to cybersecurity, making companies like CrowdStrike (NASDAQ: CRWD) and SentinelOne (NYSE: S) excellent investment opportunities. But is there an advantage to buying one over the other now? Both companies' base products are AI-powered protection platforms that analyze digital activity and learn to spot the threats among the normal activity. They deploy their software to network endpoints -- in other words, laptops, smartphones, and other devices that can access a client's internal network. By protecting these devices, companies make it harder for cyberattackers to gain access to their internal networks, where they might steal sensitive information, delete files, interfere with systems, or even lock them down with ransomware to extort payments from their victims. While endpoint protection is how both companies land clients, each bolsters its offerings with an array of other cybersecurity products that clients can use to create a protection suite tailored to their unique situations. Since these two direct competitors offer highly similar product types, it's hard to declare either a winner on this front from an investor perspective. Winner: Tie. From a sheer size perspective, CrowdStrike is the clear winner. During its fiscal 2026 first quarter, which ended April 30, CrowdStrike's annual recurring revenue (ARR) rose to $4.4 billion. SentinelOne's ARR of $948 million in its fiscal Q1 was less than a quarter of that. While size doesn't always matter, in this case, it does. Because so many more companies use CrowdStrike's platform, it's more likely that any given IT professional will have at least one contact already on its client list. If CrowdStrike is doing a great job with those clients, word will spread, and it will likely receive more serious consideration in future cybersecurity bidding processes. This advantage cannot be understated. Indeed, it's one of the reasons why CrowdStrike's growth has remained strong despite its size. Winner: CrowdStrike In terms of growth rates, SentinelOne is slightly outperforming CrowdStrike in this category. However, this should be no surprise because SentinelOne is a much smaller company. In fiscal Q1, SentinelOne's ARR rose 24% year over year, while CrowdStrike's increased 22% year over year. While I will give the point to SentinelOne, it's important to understand that CrowdStrike is growing from a much larger base than SentinelOne, making this close call all the more impressive for CrowdStrike. Winner: SentinelOne Due to its smaller size and focus on top-line growth, SentinelOne is far from profitable, while CrowdStrike has achieved intermittent profitability (although it reverted to a negative operating margin and a loss in its most recent quarter). SentinelOne is far from breaking even, but CrowdStrike was in this same position about five years ago. There's no reason not to expect SentinelOne to follow a similar path to profitability, but it will take some time. Meanwhile, CrowdStrike should eventually turn a profit again, as it has proven that it can do that. Winner: CrowdStrike CrowdStrike is leading this battle of the stocks so far, but SentinelOne is about to change the narrative with one jaw-dropping metric. CrowdStrike is the most popular cybersecurity stock in the market, and as a result, it has been bid up to expensive levels. From a price-to-sales (P/S) standpoint (the best metric to use to compare these companies since CrowdStrike flips between profitable and unprofitable, while SentinelOne is years away from profits), CrowdStrike has gotten far more expensive than SentinelOne over the past few years. CrowdStrike stock is now five times more expensive than SentinelOne, which is hard to believe, considering they compete in the same industry and are growing at nearly identical rates. This leads me to believe that CrowdStrike's stock has been overly hyped up while SentinelOne has been forgotten. While I'm OK with valuing CrowdStrike at a premium due to its market leadership position, this is far too great a premium to pay. SentinelOne is a dirt-cheap stock, and CrowdStrike is almost too expensive to consider. While I have been a long-term CrowdStrike bull, I'd be a bit cautious about buying the stock at its current lofty valuation. As a result, I think SentinelOne is the better cybersecurity investment right now. Before you buy stock in CrowdStrike, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and CrowdStrike wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Keithen Drury has positions in CrowdStrike. The Motley Fool has positions in and recommends CrowdStrike. The Motley Fool has a disclosure policy. Better Cybersecurity Stock: CrowdStrike or SentinelOne? was originally published by The Motley Fool Sign in to access your portfolio
